Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $1.68
- Average 1Y price target
- $7.50+346.43%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity3
- P/E1
- P/B3
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 2 | $3.00 |
| All time | 8 | $13.13 |
Recent rating changes
The latest 38 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 21, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 20, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Nov 17, 2025 | Leerink Partners | downgrade | Outperform | Market Perform |
| May 16, 2025 | Chardan Capital | maintain | Buy | Buy |
| Apr 3, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 28, 2025 | Guggenheim | maintain | Buy | Buy |
| Mar 24, 2025 | Chardan Capital | maintain | Buy | Buy |
| Mar 21, 2025 | Guggenheim | maintain | Buy | Buy |
| Mar 20, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 22, 2025 | Guggenheim | maintain | Buy | Buy |
| Dec 30, 2024 | Piper Sandler | maintain | Overweight | Overweight |
| Nov 7, 2024 | Chardan Capital | maintain | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 17, 2024 | Piper Sandler | maintain | Overweight | Overweight |
| Jun 4, 2024 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 12, 2024 | Piper Sandler | maintain | Overweight | Overweight |
| Mar 15, 2024 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 15, 2024 | Canaccord Genuity | maintain | Buy | Buy |
| Dec 7, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 28, 2023 | JP Morgan | downgrade | Overweight | Neutral |
| Aug 10, 2023 | Piper Sandler | maintain | Overweight | Overweight |
| Aug 10, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 10, 2023 | EF Hutton | maintain | Buy | Buy |
| Aug 10, 2023 | Chardan Capital | maintain | Buy | Buy |
| May 12, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 17, 2023 | EF Hutton | maintain | Buy | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 6, 2023 | SVB Leerink | maintain | Outperform | Outperform |
| Jan 6, 2023 | Piper Sandler | maintain | Overweight | Overweight |
| Jan 6, 2023 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 6, 2023 | EF Hutton | maintain | Buy | Buy |
| Nov 14, 2022 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 17, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 29, 2022 | SVB Leerink | maintain | Outperform | Outperform |
| Nov 19, 2021 | SVB Leerink | maintain | Outperform | Outperform |